| Primary |
| Product Used For Unknown Indication |
44.2% |
| Blood Cholesterol Increased |
11.9% |
| Hypercholesterolaemia |
9.2% |
| Drug Use For Unknown Indication |
7.5% |
| Coronary Artery Disease |
3.7% |
| Drug Use For Unknown Indication |
3.1% |
| Blood Cholesterol Abnormal |
2.4% |
| Hyperlipidaemia |
2.4% |
| Hypertension |
2.0% |
| Myocardial Infarction |
2.0% |
| Blood Cholesterol |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| High Cholesterol |
1.4% |
| Myocardial Infarction |
1.0% |
| Atrial Fibrillation |
1.0% |
| Cholesterol High |
1.0% |
| Depression |
1.0% |
| Dyslipidaemia |
1.0% |
| Transient Ischaemic Attack |
1.0% |
| Antiplatelet Therapy |
0.7% |
|
| Rhabdomyolysis |
22.5% |
| Myalgia |
10.1% |
| Rash |
7.9% |
| Sleep Disorder |
5.6% |
| Myopathy |
4.5% |
| Neuropathy Peripheral |
4.5% |
| Swelling Face |
4.5% |
| Depression |
3.4% |
| Musculoskeletal Discomfort |
3.4% |
| Myoglobin Blood Increased |
3.4% |
| Myositis |
3.4% |
| Pain |
3.4% |
| Subdural Haematoma |
3.4% |
| Tremor |
3.4% |
| Vision Blurred |
3.4% |
| Weight Decreased |
3.4% |
| Weight Increased |
3.4% |
| Amnesia |
2.2% |
| Dyspnoea |
2.2% |
| Exposure Via Body Fluid |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
66.0% |
| Hypercholesterolaemia |
5.4% |
| Hypertension |
5.4% |
| Blood Cholesterol Increased |
4.6% |
| Drug Use For Unknown Indication |
3.1% |
| Type 2 Diabetes Mellitus |
1.9% |
| Blood Pressure |
1.5% |
| Depression |
1.5% |
| Blood Pressure High |
1.2% |
| Parkinson's Disease |
1.2% |
| Urinary Tract Infection |
1.2% |
| Antiplatelet Therapy |
0.8% |
| Asthma |
0.8% |
| Bronchitis |
0.8% |
| Cardiac Disorder |
0.8% |
| Cholesterosis |
0.8% |
| Coronary Artery Bypass |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Hirsutism |
0.8% |
| Hormone Therapy |
0.8% |
|
| Rhabdomyolysis |
15.9% |
| Angioedema |
9.1% |
| Myalgia |
9.1% |
| Toxicity To Various Agents |
9.1% |
| Vomiting |
9.1% |
| Liver Function Test Abnormal |
4.5% |
| Oedema Peripheral |
4.5% |
| Pancreatitis Acute |
4.5% |
| Pulmonary Artery Stenosis |
4.5% |
| Throat Irritation |
4.5% |
| Weight Decreased |
4.5% |
| Blood Disorder |
2.3% |
| Cardiac Procedure Complication |
2.3% |
| Cataract |
2.3% |
| Depression |
2.3% |
| Diabetes Mellitus |
2.3% |
| Dyspnoea |
2.3% |
| Exposure During Pregnancy |
2.3% |
| Exposure Via Ingestion |
2.3% |
| Headache |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.2% |
| Hypertension |
12.4% |
| Plasma Cell Myeloma |
11.6% |
| Multiple Sclerosis |
8.0% |
| Type 2 Diabetes Mellitus |
6.9% |
| Osteoporosis |
4.7% |
| Prostate Cancer Metastatic |
3.6% |
| Diabetes Mellitus |
3.4% |
| Depression |
2.6% |
| Gait Disturbance |
2.6% |
| Chronic Myeloid Leukaemia |
2.1% |
| Prophylaxis |
2.1% |
| Dementia |
2.0% |
| Chronic Lymphocytic Leukaemia |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Myelodysplastic Syndrome |
1.6% |
| Nephrogenic Anaemia |
1.6% |
| Breast Cancer |
1.5% |
| Colorectal Cancer Metastatic |
1.3% |
| Osteoporosis Prophylaxis |
1.1% |
|
| Vomiting |
18.9% |
| Renal Failure Acute |
8.0% |
| Pancreatitis |
7.0% |
| Syncope |
7.0% |
| Urinary Tract Infection |
6.5% |
| Nausea |
5.5% |
| Weight Decreased |
4.5% |
| Tremor |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Rash |
3.5% |
| Rectal Haemorrhage |
3.5% |
| Renal Impairment |
3.5% |
| Somnolence |
3.5% |
| Diarrhoea |
3.0% |
| Malaise |
3.0% |
| Renal Failure |
3.0% |
| Sepsis |
3.0% |
| Stress Fracture |
3.0% |
| Urticaria |
3.0% |
| Vision Blurred |
3.0% |
|
